好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Advances in Chronic Migraine

Sunday 04/22/12
02:00 PM - 06:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
PM Half-Day Course
Gretchen E. Tietjen, MD
Participants should become familiar with the risk factors for, and the pathophysiology of chronic migraine. In addition, participants will receive an update on advances in migraine neuroimaging, and learn about emerging biomarkers linking migraine to both its risk factors and comorbidities.
No CME available
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Didactic, Interactive

Program Evaluations

Event Timeline
02:00 PM - 02:45 PM Pathophysiology of chronic migraine: what do we know?
K.C. Brennan, MD, FAAN
02:45 PM - 03:00 PM Questions and Answers
K.C. Brennan, MD, FAAN
03:00 PM - 03:45 PM Advances in Functional Imaging and Neurophysiology of Chronic Migraine
Sheena K. Aurora, MD
03:45 PM - 04:00 PM Questions and Answers
Sheena K. Aurora, MD
04:00 PM - 04:15 PM Break
04:15 PM - 05:00 PM Emerging Biomarkers in Migraine and Its Comorbidities
Gretchen E. Tietjen, MD
05:00 PM - 05:15 PM Questions and Answers
Gretchen E. Tietjen, MD
05:15 PM - 06:00 PM Tough Topics in Migraine. A Case-Based Discussion of PTSD, Hormones, Stroke, and Hypermobility Syndrome
Faculty Disclosures
Gretchen E. Tietjen, MD Dr. Tietjen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Tietjen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CME Outfitters. An immediate family member of Dr. Tietjen has stock in Johnson & Johnson.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of C2N Diagnostics. Dr. Aurora has stock in Impel Neurpharma.
K.C. Brennan, MD, FAAN No disclosure on file